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Abstract
The joint sequencing of related genomes has become an important means to discover rare variants. Normal-tumor
genome pairs are routinely sequenced together to find somatic mutations and their associations with different
cancers. Parental and sibling genomes reveal de novo germline mutations and inheritance patterns related to
Mendelian diseases.
Acute lymphoblastic leukemia (ALL) is the most common paediatric cancer and the leading cause of cancer-related
death among children. With the aim of uncovering the full spectrum of germline and somatic genetic alterations
in childhood ALL genomes, we conducted whole-exome re-sequencing on a unique cohort of over 120 exomes of
childhood ALL quartets, each comprising a patient’s tumor and matched-normal material, and DNA from both
parents. We developed a general probabilistic model for such quartet sequencing reads mapped to the reference
human genome. The model is used to infer joint genotypes at homologous loci across a normal-tumor genome
pair and two parental genomes.
We describe the algorithms and data structures for genotype inference, model parameter training. We
implemented the methods in an open-source software package (QUADGT) that uses the standard file formats of
the 1000 Genomes Project. Our method’s utility is illustrated on quartets from the ALL cohort.
Background
Acute lymphoblastic leukemia (ALL) is the most common
paediatric cancer and the leading cause of cancer-related
death among children. Advances in the understanding of
the pathobiology of ALL have led to risk-targeted treat-
ment regimes and increased survival rates, but treatment
is still far from optimal. Childhood ALL arises after the
acquisition of a series of DNA sequence abnormalities.
These initiating events, or so-called driver mutations, ulti-
mately confer a selective growth advantage, and are cau-
sally implicated in cancer development. A central goal of
cancer genome analysis is the identification of cancer
genes that, by definition, carry driver mutations.
Next-generation sequencing (NGS) technologies [1]
have enabled the genome-wide identification of human
disease-related variants. Analysis pipelines have been
established for the large-scale sequencing of individual
tumor genomes [2]. Briefly, short sequencing reads are
collected from the tumor sample, mapped to the refer-
ence genome assembly, and the set of aligned reads are
used to infer variations across the genome at homolo-
gous loci covered with multiple reads. The sequence
variants in the tumor genome may be the result of
somatic mutations, or constitutional variants preserved
in the somatic lineage. In order to distinguish somatic
mutations from conserved variants, it is necessary to
sequence normal and tumor samples side by side. The
Cancer Genome Atlas Network [3] catalogues somatic
mutations in different cancers using such normal-tumor
pairs.
In general, genetic relationships (like normal-tumor
pairs) can be efficiently exploited in genotype inference
[4,5]. Inherited and de novo mutations can be traced
through jointly sequenced family relatives [6]. Here, we
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consider variant detection in normal-tumor pairs
coupled with parental samples. Such quartet data are
used to categorize variants in the tumor and normal
genomes by their origin: see Figure 1. One can readily
classify inherited variants and de novo germline muta-
tions by comparing the genotypes in the trio of normal
and parental genomes. Likewise, somatic mutations cor-
respond to differences between the normal and tumor
genomes.
While sequencing an entire human genome is still too
expensive for the average research laboratory, various tar-
get-enrichment techniques [8] are available for sequencing
only regions of interest. In particular, sequencing the so-
called exome covering all gene-coding regions, has been a
routine step in medical applications [9]. Through our
ongoing paediatric oncogenomics study, we conducted
whole exome deep re-sequencing of a unique cohort of
over 120 exomes of childhood ALL quartets, consisting of
the patient’s tumor and matched-normal material as well
as DNA from both parents.
Existing software tools
Various bioinformatics tools have been developed for
genotyping individual genomes from sequencing data,
including SNVMix [10], VarScan [11], and The Genome
Analysis Toolkit GATK [12,13]. A couple of methods
have been developed for the purpose of joint genotyping
of paired normal-tumor samples, including SomaticSni-
per [14], MutationSeq [15], and JointSNVMix [16].
SomaticSniper and MutationSeq employ machine-learn-
ing techniques for variant classification; JointSNVMix is
based on a full Bayesian model incorporating prior geno-
type distributions, somatic mutations, and sequencing
base call errors. The Strelka software package [17] infers
joint tumor-normal genotypes in a Bayesian model that
also considers tumor sampling impurity: DNA collected
from the tumor sample is usually “contaminated” to
some degree with the normal tissue, and therefore the
sequencing reads come from a mixture of normal and
tumor genomes. To our knowledge, no existing variant
caller incorporates somatic and germline mutation mod-
els simultaneously to handle quartet data as in our data
sets.
Our contribution
We infer the four genotypes jointly in a framework that
respects the rules of inheritance in the germline and
somatic lineages. Aside from assigning belief to de novo
and somatic mutations, we hypothesized, constrained pat-
terns in one lineage have an indirect beneficial effect on
the inference in other lineages. In particular, the “triangu-
lation” of the normal genome by related genomes means
Figure 1 Alignments for the normal, tumor, and parental reads samples highlight putative somatic and germline mutations. The
illustration shows a region along chromosome 12, displayed in the Integrative Genomics Viewer [7]. Mismatched bases are highlighted.
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that genotypes and lineage-specific mutations can be
resolved more reliably: information from the parental gen-
otypes reinforce the inference of somatic mutations, and
tumor sequencing reads help to recognize constitutional
mutations. We present a Bayesian framework that incor-
porates prior parental genotypes, inherited, de novo and
somatic mutations, as well as tumor-sampling impurity
and sequencing errors. All model parameters are esti-
mated in an expectation-maximization algorithm [18].
Methods
Probabilistic model
Figure 2 illustrates our model of single-nucleotide poly-
morphisms at homologous loci across four genomes
linked by inheritance and somatic mutations. The model
quantifies the descent-by-modification relationships
between the unknown genotypes via three sets of
parameters. First, a genotype frequency model is assumed
for the parental genotypes. Second, we assume a standard
DNA substitution model for the frequency of germline
mutations. The parental diploid genotypes determine the
child’s normal genotype by Mendelian inheritance. (For
simplicity, we discuss only diploid genotypes: our imple-
mentation considers sex chromosomes in an analogous
manner, but using the appropriate inheritance model.)
Finally, another DNA substitution model with its own
parameters determines mutations in the tumor genome.
Base calls are assumed to be independent between dif-
ferent loci. The input for genotype inference at a single
locus consists of nucleotide base calls made with their
accompanying sequencing error probabilities.
Parental genotype priors
Let π[x] denote the frequency of each allele x Î {A; C;
G; T} at a given locus. The prior allele frequencies are
Figure 2 Probabilistic model for base calls covering a single locus, with dependencies among genotypes and sequencing reads. See
Equation (5) for the corresponding likelihood formula.
Bareke et al. BMC Bioinformatics 2013, 14(Suppl 5):S3
http://www.biomedcentral.com/1471-2105/14/S5/S3
Page 3 of 11
computed by using a standard DNA substitution model
quantifying the divergence from the reference genome
assembly. Assuming the simple Jukes-Cantor model
with a reference nucleotide genotype y, π[x] = ν/3 for
x = y and Π [y] = 1 − v, where v is the parental gen-
ome’s divergence from the reference. More general
divergence models and known SNP frequencies can be







where Vx→y is the model’s substitution probability from
x to y and ref is a known allele frequency.





frequency of homozygous xx and heterozygous xy geno-
types. Allele frequencies immediately determine diploid
allele frequencies in standard Hardy-Weinberg equili-
brium: φ(xx) = (π[x])2 for a homozygous locus xx, and
φ(xy) = 2π[x]π[y] for a heterozygous xy. In order to
accommodate different homozygous-heterozygous ratios,







· (π[x])2 (homozygous xx)
φ(xy) = 2 (1 − γ ) · π[x] · π[y] (hetrozygous xy)
(1)
(In other words, g is numerically analogous to the so-
called inbreeding coefficient, or F-statistic.) It is easy to
verify that haploid allele frequencies are the same at any
g setting.
Mutations and inheritance
The child’s normal genotype is determined by Mende-
lian inheritance and de novo point mutations with prob-
abilities vx®y that occur within the parental germlines.
For simplicity, germline mutations in a parental lineage
(gF, gM for father and mother, respectively) are conceived
of as mutations that result in a diploid genotype (g′F, g
′
M),
which then determine the child’s normal genotype by
Mendel’s laws.
Germline mutations follow standard molecular evolution
model for substitutions in DNA. Let X denote the parent’s
normal allele at a locus, and X’ denote the same allele at
the end of the germline before gametogenesis. The muta-
tion model specifies the probabilities that apply to every
locus vx→x′ = P
{
X′ = x|X = x}. Let χ(g′F, g′M → gN) denote
the probability of normal genotype gN given the mutated
parental genotypes g′F, g
′
M. Then c may be 0, 1, 1/2 or 1/4,
depending on the common alleles between the three
genotypes.
Tumor genotype The tumor genome undergoes muta-
tions following the same type of molecular evolution
model as the one used for germline mutations, but has
its own parameters.
Sequencing errors
The alignment at the locus is represented as a set of
basecall-error probability pairs (zk, Îk) for k = 1, ..., m.
The k-th read calls allele zk with an error probability of
0 <Îk ≤ 1. Typically, the aligned sequencing reads give
nucleotide base calls and accompanying error probabil-
ities on a logarithmic integer scale [19,20], called the
Phred scale. (In principle, the input SAM- or BAM-for-
mat file gives the Sanger-encoded sequencing error in
the QUAL column or the OQ tag.) Namely,
εk = P{sample allele is different from zk|sequencer outputs zk} = 10−qk/10 = φqk ,
where qk is the reported quality score, and
φ = 10
√
1/10 = 0.794 · · ·. Let Z denote the base call, and
Y denote the true nucleotide. We assume that errors are
unbiased in the sense that
P
{
Z = z|Y = y} =
{
1 − ε {y = z}
ε/3 {y = z}
Allele sampling and sample impurity
Aligned sequencing reads randomly sample the haploid
alleles at a given locus. Let yk be the true allele for base
call zk. The locus’ diploid genotype determines the fre-
quency ρ[y] = P{yk = y} for each possible allele y. At a
homozygous locus xx, r[y] = 1 and r[x’] = 0 for all x’ ≠ x.
At a heterozygous locus xx’, r[y] = 1/2, r[x’] = 1/2 and r
[x”] = 0 for all x” ≠ x, x’.
Impure tumor samples have a mixed distribution,
which is the linear combination of the normal and
tumor genotype distributions. For tumor reads, r[y]
comes from a mixture (0 ≤ ω ≤ 1; ω = 1 for pure tumor
sampling) between the normal and tumor genotypes:
ρ[y] = ρN[y] · (1 − ω) + ρT[y] · ω. (3)
Likelihood for aligned reads given the genotypes
Suppose we are given the set of basecall-error probabil-
ity pairs (zk, Îk) for k = 1, ..., m, representing the align-
ment at a locus. Let Zk be the random variable for base
call in read k at a fixed error rate Îk, and let Yk be the
random variable for the true sampled allele. Define the
base call probability
pk(y) = P{Zk = zk|Yk = y} =
{
1 − εk {y = zk}
εk/3 {y = zk}
Hence, P{Zk = zk} =
∑
y




The read likelihood for a given allele distribution r is
defined as
L(ρ) = p((zk, εk) : k = 1, . . . , m) = P{∀k = 1, . . . , m : Zk = zk}
Since base calls are independent across reads when










probability for read k
(4)
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Complete likelihood
Let gF, gM, gN, gTdenote the diploid genotypes for father,
mother, normal, and tumor samples, respectively. Let g′F
and g′M denote the parental genotypes after germline
mutations. These six random variables constitute the
hidden variables in our probabilistic model. The input is
a set of aligned sequenced bases from each of the four
samples:R(F), R(M), R(N), R(T). Every set R consists of
base call and error pairs (zk, Îk). The likelihood for the










×P {gF, gM, g′F, g′M, gN, gT}︸ ︷︷ ︸
= p (gF,gM,g′F,g′M,gN,gT)
(5)
The L(gF, ...) factor is the likelihood for the reads,
given the genotypes. By the independence of the sequen-
cing runs,
L(gF, gM, g′F, g
′
M, gN, gT) = L
(F)(gF)︸ ︷︷ ︸
father’s reads
× L(M)(gM)︸ ︷︷ ︸
mother’s reads
× L(N)(gN)︸ ︷︷ ︸
normal reads
× L(T)(gN, gT)︸ ︷︷ ︸
impure tumor reads
(6)
The four factors are defined by (4), via the allele fre-
quencies r that are determined by genotypes and tumor
sampling purity, as discussed above (see Allele sam-
pling and sample impurity).
The p(gF, ...) factor in (5) covers all mutation and
inheritance events, as well as the parental genotypes. By
the dependencies depicted in Figure 2,
p(gF, gM, g′F, g
′
M, gN , gT) = φ
(F)(gF) × φ(M)(gM) (parental genotype priors)
×ν(F)(gF → g′F) × ν(M)(gM → g′M) (germlinemutations)
×χ(g′F, g′M → gN) (inheritance)
×ν(T)(gN → gT) (tumormutations)
(7)
Algorithmic techniques and data structures
Our algorithmic solutions address the efficient calcula-
tion of the likelihood formula of (5), and its use in an
Expectation-Maximization (EM) framework for model
parameter setting. First, we examine a straightforward
decomposition of the likelihood formula dictated by the
assumed probabilistic graphical model.
For the EM algorithm, we need to recompute likeli-
hoods and posterior probabilities in a number of itera-
tions, which can be directly achieved by storing all
sequencing reads in memory, but such an approach may
be costly. We scrutinize the computation of read likeli-
hoods, in order to arrive at an economical data struc-
ture, also discussed in some detail, that eliminates the
need to store all base calls in memory.
Likelihood decomposition
The summation formula for the full likelihood in Equa-
tion (5) is rearranged for efficiency, using the indepen-
dencies apparent in (6) and (7). In addition, the
germline mutations can be combined with Mendelian
inheritance: define χ ′(gF, gM → gN) as
χ ′(gF, gM → gN) =
∑
g′F,g′M












χ ′(gF, gM → gN) . L(N)(gN) ×
∑
gT
ν(T)(gN → gT) . L(T)(gN, gT).
(8)
If there are G possible diploid genotypes (G = 10 for
DNA with four alleles), Equation (8) shows that the like-
lihood can be computed in O(G3) time, instead of O(G6)
suggested by the definition of (5). In particular, the like-
lihood computation proceeds by calculating the follow-
ing values.
LN[g] = L(N)(g) ×
∑
gT








φ(F)(g) · φ(M)(g′) · LFM[g, g′]
Read likelihoods










































by Equation (2). Note that only the called base’s fre-
quency b = r[z] appears in the formula. Define
f (β , ε) = β + ε
1 − 4β
3
, and Tβ[z] =
∏
k: zk=z
f (β , εk).
If no reads call z, then Tb[z] = 1. Equation (10) becomes
Lz(r) = Tr[z][z]. For pure diploid samples, r[z] may be 0, 1
or 1/2, corresponding to the possible subproducts for
diploid samples E[y] = T0[y] (sequencing error), C[y] = T1
[y] (homozygote yy), and H[y] = T1/2[y] (heterozygote
with y). Likelihood formulas become even more economical
with normalized subproducts C’[y] = C[y]/E[y], H’[y] = H







Homozygous sample. For a pure homozygous sample
with genotype yy (r[y] = 1 and r[z] = 0 for z ≠ y),
L(yy) = C[y] ×
∏
z =y
E[z] = C′[y] × E (11)
Heterozygous sample. For a pure heterozygous sam-
ple yy’ (y ≠ y’; r[y] = r[y’] = 1/2 and r[z] = 0 for z ≠ y,
y’), the likelihood becomes
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E[z] = H′[y] ×H′[y′] × E (12)
Impure tumor sample. The pure tumor (gT) and nor-
mal genotypes (gN) are proper diploid genotypes. Tumor
sequencing reads come from an impure sample: they
sample the tumor genotype with probability ω, and the
normal genotype with probability (1 - ω). By Eq. (3),
identical genotypes correspond to identical allele fre-
quencies r, no matter what the purity level ω is. Sup-
pose, however, that the locus has a mixture of divergent
normal and tumor genotypes. Figure 3 shows that there
are up to four correct base calls appearing in the reads,
depending on the tumor mutation pattern gN → gT.
There are 6 possible queried allele frequencies b ≠ 0, 1,
1/2 (Figure 3):
β = ρ[z] f (β , ε) β = ρ[z] f (β , ε)
1






























If the normal and tumor genotypes are identical, then
the purity is immaterial. The formulas with somatic
mutations are:




[y] × E {xx → xy} (14a)










[y] × E {xy → xx}
(14b)







[u] × E {xy → xu}
(14c)










[y] × T′ω[u] × E {xy → uu} (14d)
L(xx, yy) = T′1−ω[x] × T′ω[y] × E {xx → yy} (14e)
L(xx, yu) = T′1−ω[x] × T′ω/2[y] × T′ω/2[u] × E {xx → yu}(14f)




















[v] × E {xy → uv}
(14g)
Data structure for storing base calls
Storing individual base calls at each locus is costly,
because the sequencing coverage may be large across the
four samples. It suffices, however, to store the partial
likelihood factors appearing in Equations (11), (12) and
(14). In particular, for each locus with mapped base calls,
it is enough to store the sample-specific H’[x], C’[x], and
T′β[x] values for each called base x and the six possible
values of b, in addition to a single scaling value E. For a
sample with m base calls at the locus, (1 + 8m) variables
thus suffice, independently of read coverage. The stored
partial likelihoods are reused throughout the iterations
optimizing the model parameters at a fixed tumor purity
level ω.
Recurrent base calls In our experience, loci with identi-
cal sets of base calls reoccur at an appreciable fre-
quency, especially at lower coverages (less than about
15×) that characterize exon boundaries in exome
sequencing. We exploit recurrent patterns in the piled-
up base calls to achieve even better memory usage and
speed. Namely, we sort the base calls R at a given locus
for a given sample (by allele and quality score), and use
run-length encoding to achieve a compact characteriza-
tion h(R). The encoding is not used for higher cov-
erages or widely varying quality scores, where h would
take too many bits. Information-theoretic considerations
[21] suggest that compactly encoded R occur more
often (h is our proxy for Kolmogorov complexity). Short
codes h are placed in a small hash table to find recur-
rent calls (in our experiments with 20-30× total cover-
age by AB SOLiD sequencing reads, 20-30% savings can
be achieved this way).
Figure 3 Allele frequencies with impure normal-tumor genotypes that differ from each other. Reads sample the tumor with probability
ω, and the normal genotype with 1 - ω.
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Parameter optimization and genotype inference
The genotypes, germline and tumor mutations are
inferred by carrying out the summation of (5) for a
restricted set of genotypes in order to calculate posterior
probabilities. For example, in order to infer the child’s




φ(F)(gF) · L(F)(gF) · φ(M)(gM) · L(M)(gM) · χ ′(gF, gM → g).





Model parameters are optimized using the EM algorithm
[18]. In one iteration, likelihoods and various posterior
probabilities are computed across all loci in the so-called
E-step, which are then used to set the model parameters
for the next iteration in the so-called M-step. The itera-
tions continue until convergence is achieved. Among the
optimized model parameters, the parental genotype priors,
the germline and tumor mutation parameters are opti-
mized through multiple iterations using the same set of
precalculated partial likelihoods.
Setting the single parameter of the Jukes-Cantor
model for the germline and tumor mutations is fairly
straightforward by using posterior probabilities. For
example, the tumor mutation parameter ν(T) is set by
summing the posterior probabilities for allele substitu-





gN,gT α(gN, gT) · pj(gN, gT)
2N
, (15)
where N is the number of loci, pj(gN, gT) is the poster-
ior probability for a normal-tumor genotype pair at
locus j, and a(g, g’) is the expected number of substitu-
tions for the two alleles given the diploid genotypes.
In order to set the tumor purity ω, the partial likeli-
hoods need to be recomputed (for different Tb values)
by reading the input read-mapping files at each itera-
tion. At the same time, we compute a calibrated map
μ : {0, 1, . . . , 93} → [0, 1] from reported base-calling
qualities to sequencing errors in the same framework.
Note that both μ and ω have well-estimated initial
values (μ starts with the canonical Phred-scaled values,
and ω is estimated experimentally).
Decomposing zygosity and divergence For the purposes
of parameter inference, consider the following machine
realizing the formulas for the parental genotype priors
of (1). Upon receiving a heterozygous genotype xy, it
flips either allele to output homozygous xx or yy with g
/2 probability each. Otherwise, with probability (1 - g),
the output is the same heterozygote xy. Homozygous
genotypes are output without any change. Clearly, if the
input genotype distribution is for Hardy-Weinberg, then
the machine’s output is distributed by the probabilities
of (1). Accordingly, the divergence and heterozygosity
parameters for the parental genotype prior j are
inferred by treating the machine’s input genotype as a
hidden variable. Expected frequencies for divergent
input genotypes are used to estimate the divergence
parameter, and expected frequencies for heterozygous
® homozygous “flips” are used to estimate g.
Sequencing data
Exome sequencing
We conducted validation experiments using exome-
sequencing reads for two sets of quartets (A and B) gen-
erated on the Child Health Genomics Platform of the
Sainte-Justine UHC Research Center. Sequencing reads
were produced on Applied Biosystem’s SOLiD sequencer
and mapped with the accompanying software. Table 1
summarizes statistics on the mapped sequencing reads.
Whole-genome sequencing
Tumor and normal DNA samples from Quartet B were
submitted to Illumina, Inc, for deep whole-genome
sequencing using the standard operating procedures of
the HiSeq 2000 sequencing platform. Table 1 sum-
marizes coverage statistics and tumor impurity. The
whole-genome data was further analyzed for somatic
mutations with CASAVA and Strelka [17] by Illumina,
Inc.
Implementation
We incorporated the presented methods into an open-
source Java software package called QUADGT, using
the standard file formats of the 1000 Genomes Project
(SAM v1.4 [20] for input and VCF v4.1 [22] for output).
Any of the input files may be missing, which makes
QUADGT suitable to analyze sets with just normal-
tumor samples, or just parental-offspring trios.
The probabilistic framework enabled us to couple the
inference with confidence measures in the form of qual-
ity scores computed from posterior probabilities. The
quality scores accompany sample-specific genotype calls
(VCF’s GQ field), as well as the joint genotyping for the
four samples (VCF’s QUAL column). The posterior
probabilities for germline and somatic mutations are cal-
culated, as well, by summing across all pertinent geno-
type assignments. The program specifically introduces
ambiguity in the genotyping calls to meet prescribed
quality scores: a definite x/y base call in a sample is
replaced by x/. or ./y, and then by ./. in a greedy man-
ner, in order to achieve high specificity.
Parallelization
The E-step of the optimization, where sums of posterior
probabilities are calculated across loci, is well-suited to
parallelization. In our implementation, we use a hash
key computed at each locus to assign the calculations to
different computing threads running in parallel.
Bareke et al. BMC Bioinformatics 2013, 14(Suppl 5):S3
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Availability
The QUADGT software package is publicly available at
http://www.iro.umontreal.ca/~csuros/quadgt/.
Results and discussion
We used two quartet data sets (A and B) to compare
independent and joint variant detection. Figure 1 sum-
marizes the coverage statistics for the quartets. Exome-
sequencing reads at 5-6× coverage per sample were
mapped to the human reference, and we inferred gen-
ome variants using our software package QUADGT.
The entire analysis pipeline for one quartet set, includ-
ing model training and genotyping, took about 12 hours
(wall-clock time) on standard multi-core computer
workstations with 16 Gbytes of memory.
Exome-sequencing data from Quartet A was used to
assess the concordance of genotyping calls by QUADGT
and a well-established variant caller, The Genome Ana-
lysis Toolkit [12]. We used independently produced
whole-genome (WG) sequencing reads for the normal-
tumor pair in Quartet B (with 124× total coverage, see
Table 1) to gauge the two variant callers’ sensitivity.
Concordance experiments
Table 2 compares individual genotyping calls made by
the Genome Analysis Toolkit [12] and QUADGT on a
small example consisting of calls on chromosome 12
(parameters were set to result in a comparable number
of genotyping calls). The table illustrates that most calls
are made in agreement between the two programs. The
known relationships between the samples ensure the
consistency of calls made by QUADGT, resulting in
only 4 putative de novo germline mutations. GATK,
ignorant of the relations, has 327 cases where a normal
allele does not appear at either parent, which is by at
least two magnitudes higher than what one would
expect based on human intergeneration mutation rates
[6]. GATK genotypes imply a large number (520) of
somatic mutations, as well. As with de novo mutations,
the joint calls by QUADGT are more conservative: only
14 somatic mutation calls are made.
Sensitivity assessment
The normal-tumor pair in Quartet B was submitted to
Illumina, Inc. for deep whole-genome (WG) sequencing
and somatic mutation calling. Table 3 tallies the WG
somatic calls with coverage by exome data. Based on the
WG sequencing data, 1817 loci have somatic mutations,
of which 40 are covered by exome reads to sufficient
depth (Table 3, b). Some of the 40 WG somatic calls
have no or weak support (lines c and e) in exome reads,
since with at most one exception, all normal and tumor
base calls are identical with the reference. The remain-
ing 24 WG somatic calls (line f) with sufficient exome
read coverage and non-reference base calls are not
beyond the reach of the variant callers to discover
somatic mutations. On closer inspection, 5 WG somatic
calls fall into a 150 bp region (line g), which, judged by
largely divergent base calls, is likely to be misaligned; 4
WG somatic calls (line h) may even be erroneous. For
instance, at chr8:10078796, which has a fairly low WG
somatic quality score, the parental exome reads suggest
Table 1 Coverage statistics for two quartets used in validation experiments.
Exome sequencing (AB SOLiD system)
Total Normal Tumor Father Mother
Quartet A (chromosome 12 only)
Sites: 11 458 426
Reads: 5 530 702 1 454 529 1 396 361 1 117 647 1 562 165
Depth: 23.0 6.0 5.8 4.6 6.6
Experimental tumor purity: 0.63
QUADGT’s purity estimate: 0.41
Quartet B (all chromosomes)
Sites: 425 344 130
Reads: 134 574 732 38 156 404 34 580 382 29 997 426 31 840 520
Depth: 23.0 5.4 5.1 6.5 5.9
Experimental tumor purity: 0.97
QUADGT’s purity estimate: 0.44
Whole-genome sequencing (Illumina HiSeq 2000)
Quartet B (whole genome)
Total Normal Tumor
Depth: 123.8 48.6 75.2
Illumina’s purity estimate: 0.46
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that all four samples contain a heterozygous SNP that is
in fact found in dbSNP (rs112078536). The remaining
15 WG somatic calls (line i) have support in the exome
reads, and QUADGT discovers them all at some quality
threshold cutoffs.
Table 4 compares the sensitivity of joint and indepen-
dent genotyping using the 15 WG somatic calls with
support in exome base calls (Table 3, line i). First, it is
notable that QUADGT’s tumor purity estimation (by
Expectation-Maximization) is close to the Illumina’s
estimate from whole-genome data (see Table 1).
Table 4 suggests that the joint variant-calling in
QUADGT leads to better sensitivity than GATK, which
does not consider the relations between the genomes. In
particular, 9 out of 276 (3%) SOMATIC calls by
QUADGT with quality score at least 30 have support in
the WG data, whereas only 7 of GATK’s 667 (1%) diver-
gent genotypes of same quality threshold are validated.
Table 2 Comparison of calls made by the Genome Analysis Toolkit and QUADGT on Quartet A.
Normal genome
Heterozygous SNPs (ref/alt) Homozygous SNPs (alt/alt)
called by both QUADGT and GATK: 2100 called by both QUADGT and GATK: 945
called by GATK only: 60 called by GATK only: 500
QUADGT calls ref/ref: 4 QUADGT calls ref/ref: 0
QUADGT calls alt/alt: 9 QUADGT calls ref/alt: 206
called by QUADGT only: 839 called by QUADGT only: 17
GATK calls alt/alt: 206 GATK calls ref/alt: 9
De novo mutations
called by both QUADGT and GATK: 4
called by GATK only: 327
called by QUADGT only: 0
Tumor genome
Heterozygous SNPs (ref/alt) Homozygous SNPs (alt/alt)
called by both QUADGT and GATK: 2032 called by both QUADGT and GATK: 938
called by GATK only: 41 called by GATK only: 504
QUADGT calls ref/ref: 3 QUADGT calls ref/ref: 0
QUADGT calls alt/alt: 7 QUADGT calls ref/alt: 224
called by QUADGT only: 989 called by QUADGT only: 17
GATK calls alt/alt: 224 GATK calls ref/alt: 7
Somatic mutations
called by both QUADGT and GATK: 8
called by GATK only: 512
called by QUADGT only: 6
Table 3 Whole-genome somatic loci and exome genotyping on Quartet B.
Locus WG genotyping Exome base calls (A:C:G:T) QuadGT call
mutation quality N T F M N T F M
chr4:85818319 GG > AG 68 0:0:8:0 2:0:6:0 0:0:9:0 0:0:9:0 0/0 0/0 0/0 0/0
chr6:29965983 TT > CT 17 0:1:0:27 0:1:0:25 0:3:0:0 0:0:0:43 0/0 0/0 0/1 0/0
chr8:10078796 GG > CG 15 0:2:1:0 0:2:3:0 0:5:2:0 0:2:4:0 0/1 0/1 0/1 0/1
chr12:25289551 CC > TC 29 0:37:0:1 0:31:0:2 0:57:0:0 1:45:0:0 0/0 0/0 0/0 0/0
Genome coordinates refer to NCBI 36.1/hg18 genome build.
a. WG somatic loci in exome reads: 274
b. exome coverage ≥ 10: 40
c. only ref base calls in normal and tumor: 12
d. at least one non-ref base call in normal and tumor: 28 (= c - d)
e. exactly 1 non-ref base call in normal and tumor: 4
f. at least 2 non-ref base call in normal and tumor: 24 (= e - f)
g. within misaligned region chr19:4463156-4463205: 5
h. strong disagreement between exome and WG reads: 4
i. QUADGT calls SOMATIC: 15 (= f - (g + h)) – see Table 4
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At a quality score cutoff of 20, 12 out of 555 (2%) and 7
out of 1312 (0.5%) are validated QUADGT and GATK
predictions.
Conclusions
Sequencing multiple genomes with known pedigrees or
clonal relationships has a great promise for understanding
the development of particular diseases. Our experiments
with sequenced quartets of parents and normal-tumor
pairs illustrate that the joint calls improve the reliability of
inferred de novo and somatic mutations. The constraints
imposed by the known relationships greatly improve the
consistency of calls between different samples, and ulti-
mately help to delineate the single nucleotide polymorph-
isms that can be associated with the disease.
A future release of the software is now under develop-
ment that incorporates more nuanced substitution models
with variable rates, transition-transversion ratios and
nucleotide composition, as well as site-specific priors rely-
ing on public variant databases and gene annotations.
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